Paratek Pharmaceuticals 
Welcome,         Profile    Billing    Logout  
 7 Products   7 Diseases  7 Products   9 Trials   1145 News 
20 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nuzyra (omadacycline) / Paratek Pharmaceuticals
NCT04460586: Pharmacokinetics of Omadacycline in Cystic Fibrosis

Completed
4
9
US
Omadacycline Injection [Nuzyra], Omadacycline Oral Tablet [Nuzyra]
Paul Beringer, Paratek Pharmaceuticals Inc
Cystic Fibrosis
12/23
12/23
NCT05515562: Effects of Intravenous (IV) Omadacycline on Gut Microbiome

Completed
4
8
US
Omadacycline Injection, Omadacycline oral
Wake Forest University Health Sciences, University of Houston, High Point University, Paratek Pharmaceuticals Inc
Microbial Colonization
07/23
07/23
ChiCTR2500099844: Clinical Study on the Efficacy and Safety of Omadacycline in the Treatment of Brucellosis

Not yet recruiting
4
350
 
no;
The First Affiliated Hospital of Xi'an Jiaotong University; The First Affiliated Hospital of Xi'an Jiaotong University, Beijing Wei'ai Public Welfare Foundation
Brucellosis
 
 
public, NCT06162286: A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

Recruiting
3
100
RoW
Omadacycline, Moxifloxacin
Zai Lab (Hong Kong), Ltd.
Community-acquired Bacterial Pneumonia
01/25
11/25
NCT04779242 / 2020-002986-32: Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

Completed
3
670
Europe, RoW
Omadacycline, NUZYRA, Moxifloxacin, Avelox
Paratek Pharmaceuticals Inc
Community-acquired Pneumonia, Bacterial Pneumonia
03/24
03/24
PTK0796-NTM-20203, NCT04922554: Oral Omadacycline Vs. Placebo in Adults with NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Completed
2
66
US
Omadacycline Oral Tablet, Nuzyra, Placebo, placebo tablets
Paratek Pharmaceuticals Inc
Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterial Pulmonary Infection
06/24
07/24
CORGI, NCT05753215: Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

Recruiting
2
180
US
Omadacycline Pill, nuzyra, Standard of Care
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Chapman University, Paratek Pharmaceuticals Inc
Bone Infection, Joint Infection, Bone and Joint Infection
12/25
12/25
NCT06030219: Microbiome Effect of Omadacycline on Healthy Volunteers

Completed
1
32
US
Omadacycline, Vancomycin Pill, Moxifloxacin
University of Houston, Paratek Pharmaceuticals Inc
Healthy Volunteers
09/23
09/23
NCT05217537: Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections

Recruiting
1
40
US
Omadacycline Injection [Nuzyra], NUZYRA, Omadacycline Oral Tablet
Paratek Pharmaceuticals Inc
Bacterial Infections
09/24
09/24
NCT06462326: A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers

Completed
1
24
RoW
Moxifloxacin Oral Tablet, Avelox, Omadacycline Oral Tablet, NUZYRA
Zai Lab (Hong Kong), Ltd.
Healthy Volunteer
09/24
09/24
NCT04714411: Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis

Recruiting
N/A
600
US
Omadacycline
Methodist Health System
Diabetic Foot Infection
08/23
08/24
ChiCTR2300069539: Clinical efficacy study of omadacycline in hospital-acquired pneumonia / ventilator-associated pneumonia

Recruiting
N/A
60
 
Routine treatment + omadacycline ;Routine treatment + Tegacyclin
Lanzhou University Second Hospital; Lanzhou University Second Hospital, Guangdong Zhong Nanshan Medical Foundation Research Grant Fund
Hospital-acquired pneumonia/ Ventilator-associated pneumonia
 
 
Seysara (sarecycline) / Almirall
NCT06461299: Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis

Completed
4
9
US
Seysara Oral Product
The Dermatology Institute of Boston
Perioral Dermatitis
03/24
03/24
ESPRIT, NCT05836753: Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy

Recruiting
2
120
RoW
Sarecycline Tablet, Placebo tablets of Sarecycline tablets
Beijing Tiantan Hospital, NeuroDawn Pharmaceutical Co., Ltd.
Ischemic Stroke, Acute
11/23
12/23
TASER, NCT05010538: Sarecycline Truncal Acne Safety and Efficacy Response

Completed
N/A
10
US
Sarecycline, Seysara®
Angela Moore, Almirall, SAS
Acne Vulgaris
06/21
08/21
Xhance (fluticasone propionate intranasal spray) / Paratek Pharmaceuticals
2019-000368-12: A 24-week study to find out if the nasal spray containing fluticasone propionate administered twice a day provides improvement and is safe for patients suffering from chronic sinusitis, and with or without nasal polyps.

Not yet recruiting
3
378
Europe
OptiNose Fluticasone, OPN-375, Nasal spray, suspension
OptiNose US, Inc., OptiNose US, Inc.
Chronic sinusitis, Chronic sinusitis, Diseases [C] - Ear, nose and throat diseases [C09]
 
 
OPN-FLU-CS-3206, NCT03960580 / 2019-000648-86: Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps

Completed
3
223
Europe, US, RoW
OPN-375
Optinose US Inc.
Chronic Rhinosinusitis
05/22
05/22
Re-Open 3, NCT06850805: Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps

Recruiting
3
84
US
OPN-375, Placebo
Optinose US Inc.
Chronic Rhinosinusitis Without Nasal Polyps
03/28
10/28
NCT03747458: OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Recruiting
3
120
US
OPN-375
Optinose US Inc.
Bilateral Nasal Polyposis
03/26
03/26
oxytocin intranasal (OPN-300) / Paratek Pharmaceuticals
2014-005452-26: Effect of intranasal oxytocin on sosial cogitive tasks in autism spectrum disorder

Not yet recruiting
2
18
Europe
Oxytocin, Nasal spray, solution, Syntocinon
OptiNose AS, OptiNose AS
Autism spectrum disorder, Autism, Psychiatry and Psychology [F] - Psychological processes [F02]
 
 
OPN-019 / Paratek Pharmaceuticals
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nuzyra (omadacycline) / Paratek Pharmaceuticals
NCT04460586: Pharmacokinetics of Omadacycline in Cystic Fibrosis

Completed
4
9
US
Omadacycline Injection [Nuzyra], Omadacycline Oral Tablet [Nuzyra]
Paul Beringer, Paratek Pharmaceuticals Inc
Cystic Fibrosis
12/23
12/23
NCT05515562: Effects of Intravenous (IV) Omadacycline on Gut Microbiome

Completed
4
8
US
Omadacycline Injection, Omadacycline oral
Wake Forest University Health Sciences, University of Houston, High Point University, Paratek Pharmaceuticals Inc
Microbial Colonization
07/23
07/23
ChiCTR2500099844: Clinical Study on the Efficacy and Safety of Omadacycline in the Treatment of Brucellosis

Not yet recruiting
4
350
 
no;
The First Affiliated Hospital of Xi'an Jiaotong University; The First Affiliated Hospital of Xi'an Jiaotong University, Beijing Wei'ai Public Welfare Foundation
Brucellosis
 
 
public, NCT06162286: A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

Recruiting
3
100
RoW
Omadacycline, Moxifloxacin
Zai Lab (Hong Kong), Ltd.
Community-acquired Bacterial Pneumonia
01/25
11/25
NCT04779242 / 2020-002986-32: Omadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia

Completed
3
670
Europe, RoW
Omadacycline, NUZYRA, Moxifloxacin, Avelox
Paratek Pharmaceuticals Inc
Community-acquired Pneumonia, Bacterial Pneumonia
03/24
03/24
PTK0796-NTM-20203, NCT04922554: Oral Omadacycline Vs. Placebo in Adults with NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Completed
2
66
US
Omadacycline Oral Tablet, Nuzyra, Placebo, placebo tablets
Paratek Pharmaceuticals Inc
Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterial Pulmonary Infection
06/24
07/24
CORGI, NCT05753215: Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

Recruiting
2
180
US
Omadacycline Pill, nuzyra, Standard of Care
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Chapman University, Paratek Pharmaceuticals Inc
Bone Infection, Joint Infection, Bone and Joint Infection
12/25
12/25
NCT06030219: Microbiome Effect of Omadacycline on Healthy Volunteers

Completed
1
32
US
Omadacycline, Vancomycin Pill, Moxifloxacin
University of Houston, Paratek Pharmaceuticals Inc
Healthy Volunteers
09/23
09/23
NCT05217537: Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections

Recruiting
1
40
US
Omadacycline Injection [Nuzyra], NUZYRA, Omadacycline Oral Tablet
Paratek Pharmaceuticals Inc
Bacterial Infections
09/24
09/24
NCT06462326: A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers

Completed
1
24
RoW
Moxifloxacin Oral Tablet, Avelox, Omadacycline Oral Tablet, NUZYRA
Zai Lab (Hong Kong), Ltd.
Healthy Volunteer
09/24
09/24
NCT04714411: Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections and Acute Osteomyelitis

Recruiting
N/A
600
US
Omadacycline
Methodist Health System
Diabetic Foot Infection
08/23
08/24
ChiCTR2300069539: Clinical efficacy study of omadacycline in hospital-acquired pneumonia / ventilator-associated pneumonia

Recruiting
N/A
60
 
Routine treatment + omadacycline ;Routine treatment + Tegacyclin
Lanzhou University Second Hospital; Lanzhou University Second Hospital, Guangdong Zhong Nanshan Medical Foundation Research Grant Fund
Hospital-acquired pneumonia/ Ventilator-associated pneumonia
 
 
Seysara (sarecycline) / Almirall
NCT06461299: Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis

Completed
4
9
US
Seysara Oral Product
The Dermatology Institute of Boston
Perioral Dermatitis
03/24
03/24
ESPRIT, NCT05836753: Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy

Recruiting
2
120
RoW
Sarecycline Tablet, Placebo tablets of Sarecycline tablets
Beijing Tiantan Hospital, NeuroDawn Pharmaceutical Co., Ltd.
Ischemic Stroke, Acute
11/23
12/23
TASER, NCT05010538: Sarecycline Truncal Acne Safety and Efficacy Response

Completed
N/A
10
US
Sarecycline, Seysara®
Angela Moore, Almirall, SAS
Acne Vulgaris
06/21
08/21
Xhance (fluticasone propionate intranasal spray) / Paratek Pharmaceuticals
2019-000368-12: A 24-week study to find out if the nasal spray containing fluticasone propionate administered twice a day provides improvement and is safe for patients suffering from chronic sinusitis, and with or without nasal polyps.

Not yet recruiting
3
378
Europe
OptiNose Fluticasone, OPN-375, Nasal spray, suspension
OptiNose US, Inc., OptiNose US, Inc.
Chronic sinusitis, Chronic sinusitis, Diseases [C] - Ear, nose and throat diseases [C09]
 
 
OPN-FLU-CS-3206, NCT03960580 / 2019-000648-86: Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps

Completed
3
223
Europe, US, RoW
OPN-375
Optinose US Inc.
Chronic Rhinosinusitis
05/22
05/22
Re-Open 3, NCT06850805: Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps

Recruiting
3
84
US
OPN-375, Placebo
Optinose US Inc.
Chronic Rhinosinusitis Without Nasal Polyps
03/28
10/28
NCT03747458: OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Recruiting
3
120
US
OPN-375
Optinose US Inc.
Bilateral Nasal Polyposis
03/26
03/26
oxytocin intranasal (OPN-300) / Paratek Pharmaceuticals
2014-005452-26: Effect of intranasal oxytocin on sosial cogitive tasks in autism spectrum disorder

Not yet recruiting
2
18
Europe
Oxytocin, Nasal spray, solution, Syntocinon
OptiNose AS, OptiNose AS
Autism spectrum disorder, Autism, Psychiatry and Psychology [F] - Psychological processes [F02]
 
 
OPN-019 / Paratek Pharmaceuticals
No trials found

Download Options